亚太地区下一代测序市场至 2027 年 - 按产品(平台、服务、消耗品)进行区域分析和预测;服务(基因组测序、外显子组测序、重测序、靶向测序和其他测序技术);应用(诊断、药物发现、精准医学和其他应用);和最终用户(学术和研究机构、制药和生物技术公司、医院诊所和其他最终用户)以及国家/地区

Historic Data: 2015-2016   |   Base Year: 2017   |   Forecast Period: 2018-2025


No. of Pages: 238    |    Report Code: TIPRE00005751    |    Category: Life Sciences

Asia Pacific Next Generation Sequencing Market

2017 年亚太地区下一代测序市场规模达 12.036 亿美元,预计 2018 年预测期内复合年增长率为 21.8% –到 2025 年,预计将达到 58.356 亿美元。

 

亚太下一代测序市场由于亚太地区越来越多地采用测序以及各种基因组测序计划和计划,预计在预测期内将以最高速度增长。      

市场洞察

测序技术降价

近年来,二代测序价格大幅下降。例如,第一次全人类基因组测序于2000年耗资超过37亿美元,历时13年才完成。然而,近年来其成本已降至 1,000 美元,且流程所需的天数也更少。 Illumina和罗氏等主要市场参与者推出了突破性技术,降低了测序成本和时间。测序能力的巨大飞跃以及测序技术未来的潜在应用可能是测序技术的重大进步。科学和生物技术领域预计将对社会各个层面产生影响。由于成本较低,该技术可能会被整个地区所接受,特别是在中国、印度和日本。 Life Technologies 2012 年 3 月发布的一份报告指出,印度的测序成本在未来几年可能会大幅降低。由于基因组学领域的进步等因素,不同测序方法和策略的发展市场正在不断增长。

 

< strong>测序技术的发展

分子生物学领域的进步同样增强了测序程序。过去几年,许多行业参与者提出了创新的 NGS 技术。该过程的进一步修改和自动化继续增加测序数据并减少时间。从而使研究人员能够达到人类基因组计划的重要里程碑。 NGS 使基于序列的基因表达分析成为“数字”分析。模拟技术的替代方案。它还有助于利用微阵列的广度和 qPCR 的分辨率来定量 RNA 表达。

例如,2018 年 1 月,Illumina, Inc. 在中国。基于云的中心具有存储管理和基因组数据解释的设施。该地区的类似举措和发展可能会在未来几年加速下一代测序的市场增长。

 

产品洞察

2017年,耗材细分市场占据最大市场份额,占第二位的64.0%世代测序市场(按产品)。预计到 2025 年,该细分市场将主导该地区的市场。此外,预计同一细分市场在 2018 年至 2025 年的预测期内也将出现显着增长。

 

技术洞察

2017年,按技术划分,重测序领域占据了下一代测序市场66.0%的最大市场份额。由于各个政府机构的资金不断增加以及 NGS 在重测序和靶向测序中的使用,预计该细分市场将在 2025 年占据市场主导地位。此外,预计基因组部分在 2018 年至 2025 年的预测期内将出现最快的增长速度。

 

应用见解

2017年,按应用划分,诊断细分市场占据了下一代测序市场66.0%的最大市场份额。由于发达和发展中地区测序机等技术进步的增长,预计该细分市场将在 2025 年占据市场主导地位。此外,预计该细分市场在 2018 年至 2025 年的预测期内也将出现最快的增长率。

 

结束用户洞察

学术和研究机构细分市场预计在预测期内复合年增长率为 22.4%。该地区运营的测试实验室数量和规模的增加,增加了测试实验室部分。因此,该细分市场在下一代测序市场的最终用户细分市场中占据了最大的市场份额,达 45.2%,并且很可能在未来的预测期内占据市场主导地位。

  ;   

 

< strong> 

战略见解

合作伙伴关系和产品发布被视为亚太地区下一代测序行业最常用的策略。下面列出了最近推出的一些产品和合作伙伴关系:

 

2018:

Illumina, Inc. 与中国医师协会医学遗传学会(CMGA)。该合作伙伴关系帮助启动了针对先天缺陷和罕见未确诊疾病的中国儿童的全基因组测序。

2017: 10月,华大基因旗下华大智造推出MGISEQ-2000和MGISEQ-200两个NGS平台。新产品分别是BGISEQ 50和BGISEQ 500的升级版,具有技术进步。新系统的开发旨在以相对较低的价格提供始终如一的高质量测序数据。

2017 年: PerkinElmer, Inc. 推出了其临床基因组学服务。该公司借助位于中国、美国和印度的综合实验室提供全球基因组实验室测试平台。实验室进行筛查和诊断测试,重点关注罕见遗传性疾病的下一代测序。

 

NEXT世代测序 –市场细分

 

按产品

  • 消耗品
  • 服务
  • 平台

 

按技术

  • 基因组测序
  • 外显子组测序
  • 重测序和测序靶向测序
  • 其他

 

按应用划分< /strong>

  • 诊断
  • 药物发现
  • 精准医疗
  • 其他
  •  

按完用户

  • 学术和研究机构
  • 医院和诊所
  • 制药和生物技术公司
  • 其他

 

按地理位置

  • 亚太地区
    • 中国< /li>
    • 印度
    • 日本

公司简介

  • Qiagen NV
  • 北京基因组研究所
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • 安捷伦科技
  • Eurofins Scientific
  • 牛津纳米孔技术有限公司
  • Macrogen 公司


Asia Pacific Next Generation Sequencing Strategic Insights

Strategic insights for Asia Pacific Next Generation Sequencing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-next-generation-sequencing-market-strategic-framework.webp
Get more information on this report

Asia Pacific Next Generation Sequencing Report Scope

Report Attribute Details
Market size in 2017 US$ 1,203.6 Million
Market Size by 2025 US$US$ 5,835.6 Million
Global CAGR (2017 - 2025) 21.8%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By 产品
  • 平台
  • 服务
  • 消耗品
By 服务
  • 基因组测序
  • 外显子组测序
  • 重测序
  • 靶向测序和其他测序技术
By 应用
  • 诊断
  • 药物研发
  • 精准医疗及其他应用
By 最终用户
  • 学术和研究机构
  • 制药和生物技术公司
  • 医院诊所和其他最终用户
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Qiagen N.V.
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
  • Get more information on this report

    Asia Pacific Next Generation Sequencing Regional Insights

    The regional scope of Asia Pacific Next Generation Sequencing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-next-generation-sequencing-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Next Generation Sequencing Market

    The List of Companies

    1. Qiagen N.V.
    2. Beijing Genomics Institute
    3. PerkinElmer, Inc.
    4. F.Hoffman-La Roche Ltd.
    5. Agilent Technologies
    6. Eurofins Scientific
    7. Oxford Nanopore Technologies Ltd.
    8. Macrogen Inc.
    Frequently Asked Questions
    How big is the Asia Pacific Next Generation Sequencing Market?

    The Asia Pacific Next Generation Sequencing Market is valued at US$ 1,203.6 Million in 2017, it is projected to reach US$US$ 5,835.6 Million by 2025.

    What is the CAGR for Asia Pacific Next Generation Sequencing Market by (2017 - 2025)?

    As per our report Asia Pacific Next Generation Sequencing Market, the market size is valued at US$ 1,203.6 Million in 2017, projecting it to reach US$US$ 5,835.6 Million by 2025. This translates to a CAGR of approximately 21.8% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Next Generation Sequencing Market report typically cover these key segments-

  • 产品 (平台, 服务, 消耗品)
  • 服务 (基因组测序, 外显子组测序, 重测序, 靶向测序和其他测序技术)
  • 应用 (诊断, 药物研发, 精准医疗及其他应用)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Next Generation Sequencing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Next Generation Sequencing Market report:

  • Historic Period : 2015-2016
  • Base Year : 2017
  • Forecast Period : 2018-2025
  • Who are the major players in Asia Pacific Next Generation Sequencing Market?

    The Asia Pacific Next Generation Sequencing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Qiagen N.V.
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
  • Who should buy this report?

    The Asia Pacific Next Generation Sequencing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Next Generation Sequencing Market value chain can benefit from the information contained in a comprehensive market report.